ClinicalTrials.gg
Drug

Aprocitentan clinical trials

Also written ACT-132577.

studies test it
14
open now
1
in phase 3
3
first study started
2015

How each study uses aprocitentan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the aprocitentan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Mar 2024 · TRYVIO · NDA 217686 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Aprocitentan
7
Aprocitentan 25 mg
4

Development codes

ACT-132577
10

Studies by the year they started

14 studies that test it; most in 2017 (3)

Studies that test aprocitentan, by start year
YearStudies
20151
20162
20173
20182
20203
20221
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
1
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 0

Idorsia Pharmaceuticals Ltd. (13) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (1)

Often tested with

Tested in the same studies.

Ethinyl Estradiol (1) · Levonorgestrel (1) · Rosuvastatin (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses aprocitentan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Codes

What other systems call aprocitentan · ClinicalTrials.gg INT006074

  • MeSH (NLM) C572762aprocitentanOne source NLM
  • UNII (FDA) MZI81HV01PAPROCITENTANConfirmed FDA, NLM, Wikidata
  • Wikidata Q27146161aprocitentanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C174728AprocitentanOne source FDA
  • DrugBank DB15059One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.